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Abstract
Background: Mutations that disrupt the conversion of prelamin A to mature lamin A cause the rare genetic disorder
Hutchinson-Gilford progeria syndrome and a group of laminopathies. Our understanding of how A-type lamins function in
vivo during early vertebrate development through aging remains limited, and would benefit from a suitable experimental
model. The zebrafish has proven to be a tractable model organism for studying both development and aging at the
molecular genetic level. Zebrafish show an array of senescence symptoms resembling those in humans, which can be
targeted to specific aging pathways conserved in vertebrates. However, no zebrafish models bearing human premature
senescence currently exist.
Principal Findings: We describe the induction of embryonic senescence and laminopathies in zebrafish harboring disturbed
expressions of the lamin A gene (LMNA). Impairments in these fish arise in the skin, muscle and adipose tissue, and
sometimes in the cartilage. Reduced function of lamin A/C by translational blocking of the LMNA gene induced apoptosis,
cell-cycle arrest, and craniofacial abnormalities/cartilage defects. By contrast, induced cryptic splicing of LMNA, which
generates the deletion of 8 amino acid residues lamin A (zlamin A-D8), showed embryonic senescence and S-phase
accumulation/arrest. Interestingly, the abnormal muscle and lipodystrophic phenotypes were common in both cases.
Hence, both decrease-of-function of lamin A/C and gain-of-function of aberrant lamin A protein induced laminopathies that
are associated with mesenchymal cell lineages during zebrafish early development. Visualization of individual cells
expressing zebrafish progerin (zProgerin/zlamin A-D37) fused to green fluorescent protein further revealed misshapen
nuclear membrane. A farnesyltransferase inhibitor reduced these nuclear abnormalities and significantly prevented
embryonic senescence and muscle fiber damage induced by zProgerin. Importantly, the adult Progerin fish survived and
remained fertile with relatively mild phenotypes only, but had shortened lifespan with obvious distortion of body shape.
Conclusion: We generated new zebrafish models for a human premature aging disorder, and further demonstrated the
utility for studying laminopathies. Premature aging could also be modeled in zebrafish embryos. This genetic model may
thus provide a new platform for future drug screening as well as genetic analyses aimed at identifying modifier genes that
influence not only progeria and laminopathies but also other age-associated human diseases common in vertebrates.
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Introduction
The LMNA gene encodes A-type lamins, lamin A and lamin C.
The lamins are structural protein components of the nuclear
lamina and constitute a class of intermediate filaments, which form
a mesh network underlying the inner nuclear membrane that
determines nuclear shape and size [1] [2] [3] [4]. Mutations in
genes encoding the nuclear lamins and associated proteins cause a
wide spectrum of human diseases sometimes called ‘‘laminopa-
thies.’’ Diseases caused by mutations in LMNA encoding the A-
type lamins include more than 10 different clinical syndromes [5].
Major types include diseases of the striated and cardiac muscle,
lipodystrophy syndromes, peripheral neuropathies, and premature
aging. While mutations and clinical phenotypes of laminopathies
have been carefully described, explanations of the underlying
pathogenic mechanisms are still emerging. One key question is:
how do numbers of different mutations in this single gene produce
such phenotypic heterogeneity and so many different diseases.
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Heterozygous point mutations in lamin A cause Hutchinson-
Gilford progeria syndrome (HGPS) [6] [7]. Most cases of HGPS
harbor an identical de novo single-base substitution resulting in a
silent Gly-to-Gly change at codon 608 within exon 11. This
substitution creates an exonic consensus splice donor site/sequence
and activates cryptic splicing, leading to the deletion of 50 codons at
the end of prelamin A, called ‘‘progerin’’ [8] [9] [10]. The lamin A
is synthesized as the precursor molecule prelamin A [11], and the
maturation of lamin A involves the removal of 15 residues from the
C terminus cleaved by the endoprotease, Zmpste24/FACE1, via
isoprenylation and farnesylation involving a C-terminal CAAX
(cysteine-aliphatic-aliphatic-any amino acid) box [12]. Progerin
retains the CAAX box farnesylated at its C terminus, but lacks the
site for endoproteolytic cleavage, and accumulates at the nuclear
envelope, causing misshapen nuclei [13]. Importantly, sporadic use
of the cryptic splice site in LMNA exon 11 has also been
demonstrated during the normal human aging [14].
Notably, lethal neonatal laminopathies have now been identi-
fied and are caused by some specific mutations in the LMNA and
ZMPSTE24/FACE-1 genes, suggesting that certain developmental
abnormalities may be involved in some cases [15] [16] [17]. Whilst
the crucial involvement of lamin A and lamina-associated
polypeptide (LAP) 2a in the regulation of stem cells has been
suggested previously [18] [19] [20] [21] [22] [23] [24], and several
developmental studies have been performed in model animals
including Drosophila, Xenopus, chicken, cow and mouse [25][26]
[27] [28] [29] [30], the essential roles for this gene and its
requirement during early vertebrate development are still poorly
understood in vivo. In addition, several gene perturbations
identified by microarray profiling have also now been confirmed
in HGPS fibroblasts [31] [32] [33] [34], but very few have been
validated extensively in animal models.
Previous studies of HGPS fibroblasts have shown that
farnesyltransferase inhibitors (FTIs) reduce the nuclear abnormal-
ities associated with prelamin A accumulation and improve the
disease phenotypes in mouse models [35]. More recently, it has
been reported that a combined drug treatment with statins and
aminobisphosphonates, which efficiently inhibits both farnesyla-
tion and geranylgeranylation of progerin and prelamin A,
markedly improves the aging-like phenotypes and lifespan of mice
deficient in Zmpste24 [36]. These findings suggest that the
compounds may provide new therapeutic approaches to the
treatment of this devastating progeroid syndrome. However, given
the evidence of persistent disease in mice expressing a non-
farnesylated version of progerin, FTIs may not represent a
‘‘panacea’’ for this disease [37] [38]. Hence, new therapeutic
interventions need to be considered, and new vertebrate model
systems that facilitate high-throughput screening of chemical
compounds to treat HGPS and other laminopathies are also
essential. The zebrafish (Danio rerio) system has the potential to
emerge as a key vertebrate model in this regard, as zebrafish
maintain evolutionally conserved A-type (A and C) as well as B-
type (B1 and B2) lamins among vertebrates.
We here describe that two different types of morpholino
antisense oligonucleotides (MOs) directed against the zebrafish
LMNA gene. The first of these MOs (LMNA-MO1) introduces a
knockdown of zebrafish lamin A/C, and the other MO (LMNA-
MO2 or -MO2.1) induced an unique cryptic splicing in exon 11 to
generate a new truncated form (zebrafish lamin A-D8) in the
globular domain of zebrafish lamin A. These MOs caused specific
disruptions in the development of zebrafish embryos, particularly
in the mesenchymal cell lineages, which are accompanied by
either excessive apoptosis or embryonic senescence. We further
demonstrate that an FTI can efficiently inhibit the farnesylation of
zebrafish progerin (zebrafish lamin A-D37/zProgerin) and sup-
press the abnormal nuclear morphologies, muscle fiber defects and
embryonic senescence phenotypes. Accelerated aging-like symp-
toms and shortened longevity were also observed in zebrafish
expressing progerin/lamin A-D37 or even prelamin A. Our
genetic model using zebrafish may thus facilitate a high-
throughput approach to the search for novel therapeutics for
human progeroid syndromes and laminopathies associated with
nuclear-envelope abnormalities.
Results
Transgenic Expression of Zebrafish Progerin and
Prelamin A
The zebrafish LMNA gene was assigned to Linkage Group 16
(LG16) by radiation hybrid (RH) mapping of the LN54 RH panel
[39]. The zebrafish LMNA region on LG16 is syntenic with human
chromosome 1q21-23, which includes the genes adar (adenosine
deaminase, RNA-specific), mef2d (MADS box transcription enhancer factor
2), ctsk (cathepsin K), cct3 (chaperonin containing TCP1, subunit 3
(gamma)), and hfe2 (hemochromatosis type 2) in addition to LMNA. This
synteny strengthened the validity of the LMNA gene location based
on RH mapping and physical linkage, and strengthened the
identity of zebrafish LMNA as an ortholog of human LMNA. Upon
the molecular cloning of zebrafish LMNA cDNA (Fig. S1), as well
as conserved syntenic mapping analysis between the human and
zebrafish LMNA genes (Fig. 1A), we developed zebrafish models
for HGPS and laminopathies. Reverse transcriptase-PCR (RT-
PCR) analysis of adult zlamin A/C revealed ubiquitous expression
throughout the tissues, but at higher levels in the brain, heart, liver
and muscle (Fig. 1B). We also examined the protein expression of
zlamin A/C in adult tissues by western blotting analysis and found
its ubiquitous expression as anticipated, although zlamin A was
more strongly expressed in heart and higher levels of zlamin C
were evident in brain (Fig. 1B, lower panels).
As HGPS is a dominant sporadic disease caused by mutations
within exon 11 of LMNA, leading to an in frame deletion of 50
amino acids from the C-terminal tail of prelamin A (Progerin/
lamin A-D50), we first attempted to generate transgenic zebrafish
expressing a form of zebrafish lamin A with a deletion of 37 amino
acids i.e. a zlamin A-D37 (zebrafish Progerin: zProgerin)
expression construct. This was to closely mimic the effects of
human Progerin/lamin A-D50 based on the alignment of their
amino acid sequence (see Fig. 1C). We microinjected wild-type
zebrafish embryos with a zProgerin expression construct driven by
the human cytomegalovirus (CMV) promoter at the one-cell stage
of development for the generation of founder (F0) fish that showed
mosaic expression of the transgene [40]. In contrast to healthy
non-transgenic wild-type (wt) siblings (Fig. 1D, upper left
picture panel), of the 21 germline-positive F0 zebrafish injected
with enhanced green fluorescent protein (EGFP)-zProgerin, 19
(90%) were symptomatic for early spinal curvature, wasting
symptoms, and odd swimming behaviors in young- to mid-adults
(Fig. 1D, lower left and upper right picture panels), as
were 3 (25%) of 12 germline-positive fish injected with EGFP-
zebrafish prelamin A (zPrelamin A) (Fig. 1D, lower right
picture panel). The affected transgenic zebrafish developed
distended curvatures ranging from a mild bend or arch to a mild
or moderate distortion, which are similar to manifestations of
senescence reported previously [41]. Some fish had protruding
ventral or dorsal curvatures with relatively small pectoral fins,
whereas others had wavy trunks throughout (Fig. 1D). Many of
these fish also showed extensively unbalanced body shapes with
age, resulting subsequently in the onset of abnormal swimming
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behaviors in their later lives. The mean latencies of the phenotype
development in zprogerin and zprelamin A fish groups were 332
(range of 221 to 444 days) and 352 days (range of 306 to 431 days),
respectively. All of the germline-positive F0 zprogerin fish died
before reaching 2 years of age. On the other hand, non-
symptomatic F0 zprelamin A fish survived past 3 years although
the 3 symptomatic fish died before reaching 2.5 years. In order to
determine whether zprogerin and zprelamin A fish were prematurely
aging, we used senescence-associated b-galactosidase (SA-b-gal), a
hallmark of cellular senescence in vitro as well as a marker of the
organismal aging process in vertebrates including zebrafish [42]
[43] [44] [45] [46]. Sporadically enhanced SA-b-gal activity was
observed in approximately 70% of morphologically still non-
symptomatic (almost normal shaped) transgenic fish (one of
zprelamin A fish with high SA-b-gal is shown; Fig. 1E, left
picture panel). We further confirmed the appearance of these
accelerated aging symptoms in another cohort (18 months of age)
comprising uninjected wt sibling (n = 56), F0 zprogerin (n = 34), or F0
zprelamin A fish (n = 28) (Fig. 1D and E, right graphs).
Intriguingly, the frequency of abnormal body shapes was higher
in the zprogerin transgenic fish group than in the zprelamin A fish
group, whereas the SA-b-gal intensities were much higher in the
zprelamin A fish. These results suggest that accelerated aging
symptoms may develop in most of the mosaicked transgenic fish
whose cells carry a functional zprogerin or zprelamin A transgene that
is sporadically expressed.
Knockdown of The LMNA Gene in Zebrafish Embryos
Showing Muscle and Cartilage Abnormalities
Lamin A/C is ubiquitously expressed in multiple tissues from
adult zebrafish (Fig. 1B and Fig. S2), and we have also detected
the expression of the corresponding gene, LMNA, by whole-mount
in situ hybridization and semi-quantitative RT-PCR in zebrafish
embryos (Fig. S3) (Supplemental Data S1). Lamin A/C
protein expression during zebrafish embryogenesis was found to be
relatively lower than that in various adult tissues but this may be
an artifact of high yolk protein levels in embryos (Fig. 1B, lower
panel as shown for a larval sample at 6 days post
fertilization, dpf). LMNA-null mice are born with a normal
phenotype [47]. However, it has also been suggested previously
that the ectopic expression of prelamin A or exon 9-deleted
mutant lamin A affects developmental processes in the early
phases of Xenopus embryogenesis [26] [48]. To examine the
function of the type A lamins in the early development of
zebrafish, we first tested translation-block morpholino antisense
oligonucleotides (MO) (zLMNA-MO1) designed to target the
translation initiation codon (ATG) and 59-untranslated regions of
both lamin A and C. To determine the effectiveness of the
resulting knockdowns at the protein level, zLMNA-MO1-trans-
fected zebrafish AB9 fibroblasts were examined by western
blotting. Compared with untransfected cells and control 5-
mismatch MO1 (‘5 mis’ for MO1)-transfected cells, a downreg-
ulation of lamin A/C protein expression was observed (P,0.01)
(Fig. 2A). We further designed two MOs (zLMNA-MO2 and -
MO2.1) that target the splicing junction the 39 end of exon 11 to
generate aberrant splicing (Fig. 2B and Fig. S4). This cryptic
splicing of lamin A within exon 11 yields a protein with an 8-
amino acid deletion (zlamin A-D8) (Fig. 2B and Fig. 1C). This
removes the predicted site of Zmpste24/FACE1-mediated en-
doproteolytic cleavage [49], whereas the actual cleavage site in
zPrelamin A has not yet been tested. The EGFP-fused zPrelamin
A, zlamin A-D8 and zlamin A-D37/zProgerin proteins each
localized at the nuclear envelope in transgenic embryos (Fig 3, D–
F). The specific localization of the zlamin A-D8 and zlamin A-D37
proteins at the nuclear envelope showing abnormally wrinkled
misshapen structures was concurrently observed in embryos
expressing both constructs (Fig. 3E and F).
The phenotype induced by the knockdown of zebrafish lamin A/C
by different MOs during early development was not particularly
evident at the gross morphology level at 24 hours post fertilization
(hpf) (Fig. 2C), except an occasional observation of rough skin
(Fig. 2D). However, when we analyzed slow skeletal muscle fibers in
more detail by staining myosin heavy chains with an F59 antibody
(Fig. 4A, e–h), muscle damage was evidenced by a failure in slow
muscle fiber migration to the lateral surface along with irregular,
gapping (Fig. 4A, f;MO1), and/or wavy (Fig. 4A, h;MO2) muscle
fibers in approximately 50% of the zLMNA-morphants (Fig. 4B). In
contrast, no evident differences in fast muscle fibers in the morphants
were identified via the staining of myosin light chains with an F310
antibody (Fig. 4A, i–l). We further demonstrated the slow muscle
phenotype via expression of the zprogerin (zlamin A-D37) transgene.
zprogerin transgenic zebrafish embryos (,40%) showed similar slow
muscle fiber abnormalities as shown later.
We next examined craniofacial phenotypes in our morphants, as
some mutations in the LMNA gene are known to cause craniofacial
anomalies and/or disproportion in both humans and mice [50]
[51]. In zLMNA-MO1 morphants at 6 dpf, a dorsal displacement of
Meckel’s cartilage in relation to the palatoquadrate (n= 32 of 65;
49%) (red arrow in Fig. 4C, f) was observed and the jaw appeared
to be shorter in the ventral view of the head (Fig. 4C, j). In contrast,
this seemed not to be due to a reduction in the size of any elements
of the jaw apparatus but rather to a reduced angle between the
Meckel’s cartilage and the palatoquadrate. Moreover, from the
ventral view, retrognathic pharyngeal cartilage defects (a red line in
Fig. 4C, j) were identified in the ceratohyal articulates (a further
posterior position than the lateral view) (n= 18 of 65; 28%)
(Fig. 4C, j) (Table 1). Although obvious pharyngeal cartilage
defects in morphology, including retrognathic formation, were not
apparent within zLMNA-MO2 morphants (Table 1), the MO2
molecule induced a relatively hypoplastic formation of cartilage
matrix with occasionally reduced Alcian blue staining, indicating a
possible alteration of the composition of the matrix.
Figure 1. Transgenic expression of zebrafish Progerin/lamin A-D37 and prelamin A. (A) The zebrafish LMNA gene was assigned to Linkage
Group 16 (LG16) and is syntenic with human chromosome 1q21-23. Left: six genes including LMNA are located within a 10 Mb genomic region on
human chromosome 1. Right: six zebrafish homologs of these genes are listed according to the map positions on LG16. (B) RT-PCR analysis of adult
zlamin A revealing strong expression in the brain, heart, liver and muscle (upper panels). Western analysis of 6 dpf embryo lysates and 1-year old
adult tissues was preformed using an anti-chicken lamin A polyclonal antibody (ab14309), as well as an anti-mouse actin monoclonal antibody as a
loading control (lower panels). (C) Amino acid sequence alignment of the C-terminal portions in human (Homo sapiens) lamin A (Hs. lamin A) and
zebrafish (Danio rerio) lamin A (Dr. lamin A) and their deleted forms (D50 in human; D37 and D8 in zebrafish) induced by cryptic splicing events. (D)
External features of a wild-type non-transgenic sibling fish (wt; 1.5-year old). Two representative zprogerin transgenic fish with curved trunks (zlamin
A-D37; 1.5-year old) are shown. A zprelamin A transgenic fish with a wavy trunk (2.1-year old) is also shown. In these transgenic fish, spinal curvatures
and disproportional body shapes are prominently observed. Scale bars, 1 cm. Qualifications of the abnormal body shapes are shown in the right
graph (cohorts of 18 months of age). (E) SA-b-gal staining of wild-type sibling and transgenic fish (1.9-year old). Quantifications of the SA-b-gal
intensities in the fish are shown in the right graph (cohorts of 18 months of age, *P,0.01).
doi:10.1371/journal.pone.0017688.g001
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Apoptosis, Senescence, and Lipodystrophy in zLMNA
Morphants
Given the morphologies observed in our zebrafish morphants, we
assayed for apoptotic cell death in these embryos using the TUNEL
assay. Apoptotic cells were predominantly detected in the brain and
trunk of the zLMNA-MO1-injected embryos at 24 hpf (Fig. 5A, b).
On the other hand, in zLMNA-MO2-injected embryos, we observed
only a slight induction of apoptosis (Fig. 5A, d). In the control
Figure 2. Knockdown of zebrafish lamin A/C. (A) Western blot analysis of intrinsic lamin A/C in the zebrafish AB9 cells transfected with MOs. The
lower panel of blotting shows the actin control (*P,0.01). The right-side graph shows the quantitation results for the lamin A and C blot intensities
standardized by the control actin levels from three-independent experiments. (B) Agarose gel electrophoresis of the RT-PCR products of zlamin A
from embryos injected with the indicated concentrations of zLMNA-MO2. The primers used recognize exon 9 (forward primer; F-Primer) and the 39-
untranslated region (reverse primer; R-Primer). Sequence analysis revealed that the injection of zLMNA-MO2 induces a 24 bp deletion in the rear part
of exon 11. Left panel, total RNA was extracted from 24 hpf embryos after MO injection. Right panel, embryos were injected with 8 ng MO and total
RNA was extracted from 24 to 72 hpf as indicated. Lower panel, the corresponding positions of the F-Primer, R-Primer, and MO2 are schematically
presented. (C) Gross morphology of zlamin A/C-knockdown embryos. Lateral views of MO-injected embryos (4 ng) at 24 hpf are shown. (a) 5-base
mismatch control MO1 (MO1, 5-mis), (b) zLMNA-MO1 (MO1, MO), (c) 5-base mismatch control MO2 (MO2, 5-mis), (d) zLMNA-MO2 (MO2, MO). (D)
Occasionally observed rough skin phenotypes (Mild and Severe) in MO2-morphant tails are shown by comparison with a normal skin phenotype
(Normal) in the wild-type tail.
doi:10.1371/journal.pone.0017688.g002
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embryos, no significant apoptosis induction was observed (Fig. 5A,
a, c), although scattered apoptotic cells were occasionally detectable
at background levels throughout the embryos.
Given the obvious appearance of apoptotic cells in our
morphants, we assessed whether cell proliferation was altered in
any way. Although the expression of proliferating nuclear antigen
(PCNA) was not substantially affected (Fig. S5), the cell-cycle
progression was prominently disturbed in the morphants.
Progression through the S and M phases of the cell cycle, assessed
by the incorporation of 5-bromo-2-deoxyuridine (BrdU) and the
immunostaining of a mitotic marker, phosphorylated histone H3
(pH 3), respectively, was decreased in both cases in the zLMNA-
MO1 morphants (Fig. 5A, f, j, see right graph). Intriguingly,
in the zLMNA-MO2 morphants, an accelerated progression
through S phase was observed but no significant alterations
during M phase were detected (Fig. 5A, h, l, see right graph),
implicating the accumulation/arrest in S-phase with increased
DNA damage and/or dysregulated DNA repair [52].
Semi-quantitative RT-PCR was used to assay individual
morpholino-injected embryos for the expression of p53,
p21WAF1/CIP1, cyclin D1, cyclin E, and cdk2, with b-actin used as a
normalization control. A slight upregulation of p53 mRNA was
observed in zLMNA morphants (either MO1 or MO2), when
compared with wild-type embryos (data not shown) and control 5-
mismatch MO-injected embryos (Fig. 5B). In addition, a
downstream target of the p53 pathway, cyclin-dependent kinase
inhibitor 1, p21WAF1/CIP1, was also correspondingly upregulated in
the zLMNA morphants (Fig. 5B). Interestingly, neither cyclin D1
nor cyclin E, which are required for progression into G1 and
through to the start of S phase, showed any transcriptional
changes in the morphants and cdk2, which associates with cyclin E
and cyclin A during the transition from G1 to S phase, was slightly
decreased only in zLMNA-MO1-injected embryos, suggesting a
specific cell-cycle delay resulting from a total lamin A/C decrease.
These results are representative of similar analyses on additional
single embryos (wild-type, n= 4; MO1-5mis, n = 4; MO1-MO,
n=8; MO2-5mis, n = 4; MO2-MO, n= 8; data not shown) and
suggest that, in the reduced lamin A/C expression (by MO1) or a
disrupted splicing of this gene (by MO2), p21WAF1/CIP1 is
commonly activated. However, the reason for the observed
distinct increases in TUNEL-positive apoptotic cells as well as
differential cell-cycle profiles remains unclear.
Figure 3. Expression of EGFP-tagged zprelamin A, zlamin A-D8, and zlamin A-D37/zProgerin in zebrafish embryos and the nuclear
morphologies in the expressing cells. (A) EGFP-zPrelamin A expression in zebrafish embryos. (B) EGFP-zlamin A-D8 expression in zebrafish
embryos. (C) EGFP-zlamin A-D37/zProgerin expression in embryos. (D) The nuclear localization of EGFP-zPrelamin A and the nuclear morphology in
the expressing cells within the embryo. (E) The nuclear localization of EGFP-zlamin A-D8 and the nuclear morphology in the expressing cells within
the embryo. (F) The nuclear localization of EGFP-zlamin A-D37/zProgerin and nuclear morphology in the expressing cells within the embryo.
doi:10.1371/journal.pone.0017688.g003
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Recently, we have demonstrated that an embryonic (larval)
senescence phenotype caused by specific gene mutations and by
stress is readily detectable via the SA-b-gal staining of zebrafish
embryos and larva within 6 days post-fertilization (dpf) [42]. We
therefore examined the zlamin A/C-depletion (by MO1) or zlamin
A-disturbance (by MO2) effects in our morphants by staining with
SA-b-gal. Intriguingly, the zLMNA-MO2 morphants showed a
high intensity of SA-b-gal at 6 dpf, whereas zLMNA-MO1
morphants did not show significantly detectable SA-b-gal activity
(Fig. 5C).
Figure 4. The knockdown of zebrafish lamin A/C induces laminopathies associated with muscular dystrophy and craniofacial
abnormalities. (A) Muscle fiber visualization in zlamin A/C-knockdown embryos. (a–d) The left panels show a lateral view of the entire embryo
bodies and a magnified bright field view of the somites. (e–h) Lateral views of MO-injected embryos at 24 hpf stained with the F59 antibody (adaxial
cells/slow muscle fibers). In panel (f), white arrowheads indicate broken or missing muscle fibers. In panel (h), white arrowheads indicate the wavy
muscle fibers in compared with control embryos. (i–l) The right panels show cryostat sections of 48 hpf LMNA-MO injected embryos stained for fast
muscle fibers (F310). (B) Percentage of muscle phenotypes scored for MO-injected embryos at 24 hpf. The graph shows the distribution of
phenotypes observed following injections with 4 ng of MOs. Migration failure in embryos is represented in gray and wavy muscle fibers in black. The
percentage of each muscle phenotypes ‘waving’, ‘migration failure’, ‘normal’ were, respectively, MO1-5mis; 7.5%, 5.0%, 87.5%; MO1-MO; 3.8%, 46.2%,
50.0%; MO2-5mis; 6.1%, 6.1%, 87.8%; MO2-MO; 29.4%, 25.5%, 45.1%. (C) Cartilage in 6 dpf larvae were stained with Alcian blue and then whole-
mounted. (a–d) Lateral views of the head portions of living larvae are shown in the top panels. (e–h) Lateral view of Alcian blue stained larvae. (i–l)
Ventral views of Alcian blue stained larvae. The red lines indicate the ceratohyal articulates (ch), and the red arrow indicates the Meckel’s (m) to
palatoquadrate (pq).
doi:10.1371/journal.pone.0017688.g004
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Lipodystrophy is one of the hallmarks of the laminopathies and
HGPS. To thus examine whether neutral fat distribution is
affected in our current morphants, we stained whole larvae with
Oil Red O (ORO). Significant ORO lipid staining was detectable
in the control larvae as reported previously [53] [54] [55].
However, in the zLMNA morphants, a strikingly lower level of
lipids was observed in the head, otic vesicle jaw, and yolk (Fig. 6).
MO1 was found to induce a more severe lipid loss although MO2
still caused a significant lowering of these levels also. To determine
the expression levels of zebrafish peroxisome proliferator-activated
receptor-c (PPARc), relative to b-actin as a control, RT-PCR was
performed on individual morpholino-injected embryos. The result
showed that either a lamin A/C knockdown by MO1 or the
induction of cryptic splicing by MO2 is associated with decreased
PPARc mRNA levels (Fig. S6), indicating reduced adipogenic
differentiation in embryos with lipodystrophic phenotypes.
FTI Treatment of Transgenic Zebrafish Expressing
Progerin
To establish the extent of the embryonic phenotypes that arise
in lamin A-depleted zebrafish, we further studied the F1
generations of germline-positive zprogerin transgenic fish since their
F0 parents showed normal reproduction up until severe aging-like
manifestations appeared (Fig. 1D and E). Most of the zprogerin
transgenic fish embryos were morphologically normal, similar to
the morphants at 24–30 hpf (Fig. 7A). However, all of the
examined transgenic fish had the misshapen nuclei (Fig. 7B, a,
b). Once we analyzed their slow skeletal muscle fibers, striking
abnormalities with wavy migrations could be observed in a
number of cases at 24 hpf (Fig. 7C, b). The zprogerin transgenic
fish also showed obvious SA-b-gal induction even at 3.5 dpf
(Fig. 7C, e)
To demonstrate the effects of FTI in zebrafish, we then
employed a zebrafish fibroblast cell line (AB9). In FTI treated
zebrafish cells, the accumulation of prelamin A was detectable in
20 mM, suggesting that the farnesylation of intrinsic prelamin A
was prevented as was further processing of the protein (Fig. 7D,
right graph).
In zprogerin transgenic embryos, the ratio of nuclei that had
abnormal shapes was 54.364.9% (Fig. 7B). Previous studies have
shown that when the farnesylation of prelamin A in HGPS cells
and in Zmpste24-deficient cells is blocked by FTI, prelamin A does
not accumulate at the nuclear rim and the percentage of cells with
misshapen nuclei is reduced [56] [10] [57] [58] [8] [9]. To
determine whether the nuclear shape abnormalities caused by
zProgerin in our transgenic zebrafish embryos could also be
ameliorated by FTI, different concentrations of this inhibitor were
administrated to 5 hpf embryos which were further incubated for
25 h. As expected, the FTI treatment of zprogerin transgenic
embryos reduced the extent of the abnormally misshapen nuclear
morphology in a dose-dependent manner (Fig. 7B, right
graph). The frequency of misshapen nuclei expressing zProgerin
(54.364.9% in untreated condition) was reduced to 26.3616.2%
upon exposure to 100 mM FTI (P,0.05). Moreover, the slow
muscle fiber abnormalities, in addition to the onset of embryonic
senescence, in these transgenic embryos were significantly blocked
by FTI treatment (Fig. 7C, c, f). These findings are consistent
with the results in other progeria cells and animals treated with
FTI [59].
Shortened Lifespan Resulting from Stable Progerin and
Prelamin A Expression in Zebrafish
To measure lifespan, stable zprogerin or zprelamin A transgenic
fish were maintained with their wild-type siblings and their
survival was measured using Kaplan-Meier survival curves (Fig. 8).
These fish were not sterile as described above, but their observed
lifespan was significantly shorter than that of wild-type zebrafish
reported previously [41] [42]. We also examined the prelamin A
transgenic zebrafish and interestingly, these transgenic fish also
suffered from a relatively short lifespan. We maintained popula-
tions of these transgenic zebrafish and their wild-type siblings until
death, and conducted observational studies on their lifespan. We
scored the two cohorts of zprogerin transgenic fish (no genders
identified; Cohort 1, n= 102; Cohort 2, n = 54) in comparison
with their wild-type siblings (no genders identified; Cohort 1,
n = 22 and Cohort 2, n = 46), and found significant decreases in
the lifespan of the zprogerin transgenic animals (Cohort 1,
P,0.0005; Cohort 2, P,0.0001, log rank test) (Fig. 8). The plots
in Figure 8 show Kaplan-Meier survival curves and 95 percentile
confidence intervals on the cumulative probability distribution (the
survival function).
We additionally found that our zprelamin A fish cohorts (no
genders identified; n= 36) manifested a shorter lifespan compared
with that of their wild-type siblings (no genders identified; n= 91;
P,0.0001, log rank test) (Fig. 8). In both the zprogerin and zprelamin
A cases, there were significant differences found between the wild-
type siblings and the transgenic fish. These lifespan analyses of
zprogerin and zprelamin A transgenic zebrafish in accordance with
the embryonic senescence phenotypes suggest that early develop-
mental manifestations can predict a role for the LMNA gene.
Discussion
The zebrafish is a valuable vertebrate model system for the
elucidation of novel molecular pathways of aging as well as early
development [60]. In particular, this model organism develops an
array of senescence symptoms resembling those in humans [61]
[62] [63] [44], and is amenable to large-scale genetic screens that
can be targeted to conserved aging pathways in vertebrates [42].
However, the establishment of human disease-associated prema-
ture senescence-bearing fish had not been pursued previously. In
this study, we developed zebrafish progeria and laminopathy
models in three different ways: i) exogenous expression of the
zebrafish version of ‘progerin’ (zProgerin) protein, ii) translational-
block MO (zLMNA-MO1)-induced translational downregulation
to reduce lamin A/C protein levels, and iii) splice-block MO
(zLMNA-MO2)-induced cryptic splicing of LMNA, which deleted 8
amino acid residues containing the predicted site of post-
translational cleavage. First, the exogenous transgenic expression
of zProgerin/zlamin A-D37, for which anticipated similar
symptoms to MO2 morphants were anticipated, demonstrated a
shortened lifespan as well as accelerated aging in adult zebrafish.
Second, the translational-block of LMNA by MO1 induced
apoptosis, cell-cycle arrest, and craniofacial abnormalities (carti-
lage defects). In contrast, splice-block generating zlamin A-D8 with
Table 1. Cartilage defects in LMNA-MO-injected embryos.
Injection
The Number of
Injected Embryos
Ceratohyal
Defect
zLMNA-MO1 5-mis 100 0% (0/89)
MO 100 28% (18/65)
zLMNA-MO2 5-mis 100 0% (0/82)
MO 100 0% (0/78)
doi:10.1371/journal.pone.0017688.t001
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Figure 5. The knockdown of zebrafish lamin A/C induces an aberrant cell cycle, apoptosis, and senescence. (A) Apoptosis and cell cycle
analysis in 24 hpf embryos. (a–d) Lateral view of apoptotic phenotypes in MO-injected embryos using a TUNEL assay (TUNEL-positive cells are
indicated by the red fluorescence spots). zLMNA-MO1-injected embryos shows increased apoptosis in the head and trunk. (e–h) BrdU incorporation in
MO-injected embryos. zLMNA-MO2-injected embryos show increased BrdU-positive cells throughout the whole body. (i–l) MO-injected embryos
stained with anti-phospho histone H3 (pH 3). A zLMNA-MO1-injected embryo shows a decreased number of pH 3-positive cells. Quantifications of the
BrdU and pH 3 intensities in morphants are shown in right graphs (BrdU: MO1, P,0.05 for 5-mis versus MO, MO2, P,0.05 for 5-mis versus MO; pH 3:
MO1, P,0.05 for 5-mis versus MO, MO2, no significance for 5-mis versus MO). (B) Genes involved in the p53-related and cdk2 pathways were
analyzed by semi-quantitative RT-PCR in MO-injected embryos at 24 hpf. Quantifications of the bands intensities for p21 are shown in the bottom
graph (P,0.01 for 5-mis versus MO in MO1 and MO2). (C) SA-b-gal assay of 6 dpf MO-injected larvae in comparison with each control 5-mis MO.
Qualifications of the SA-b-gal activity are shown in bottom graph. The zLMNA-MO2-injected embryos revealed strong induction of SA-b-gal activity
(P,0.01 for 5-mis versus MO in MO2), whereas the zLMNA-MO1-injected embryos did not exhibit any obvious activity, compared with Cont-MO1-
injected embryos.
doi:10.1371/journal.pone.0017688.g005
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a cryptic splicing of LMNA by MO2 produced embryonic
senescence and S-phase accumulation/arrest. Interestingly, a
lipodystrophic phenotype was induced by both MO1 and MO2.
These phenotypic outcomes are summarized in Table 2 with
reference to human progeria and laminopathies. Our data also
demonstrated that long-term increased levels of not only progerin
but prelamin A in transgenic zebrafish results in a shortened
lifespan in these animals. Hence, the expression of normal
prelamin A, as well as progerin [14] [64], may be linked to
senescence induction during the physiological aging process [65]
[66].
Lamin A/C expression is closely correlated with cell differen-
tiation in metazoans, and LMNA mRNA is also developmentally
expressed in zebrafish embryos from at least the late gastrula
period (9 hpf). Some interesting observations were recently
reported for developmentally functional A-type lamins in a
comparative study of Drosophila and humans [25] [67]. On the
other hand, detailed insights into any functional role of lamin A/C
during early vertebrate development have not been obtained to
any great extent to date. Because embryonic stem cells appear to
express lamin A/C upon differentiation [20], and lamin A-
associated stem cell dysfunction has been linked to disruption of
the Wnt and Notch signaling pathways [19] [23] [18] [48], which
are essentially involved in the process of early vertebrate
development, our current observations of embryonic senescence
or apoptosis in LMNA-disturbed zebrafish might be consistent with
the dysregulation of somatic stem cells leading to organismal
premature aging. In particular, it is plausible that the loss/decrease
of plasticity and/or onset of self-renewal defects in mesenchymal
stem cells may be responsible for the specificity of accelerated
tissue degeneration, as most affected tissues in progeria are of
mesenchymal origin [18].
Between the knockdown of the LMNA gene (by zLMNA-MO1)
and the induction of mis-splicing within exon 11 of LMNA (by
zLMNA-MO2), some phenotypic differences were observed in
treated zebrafish embryos in terms of cell-cycle regulation,
apoptosis and senescence. These may be attributable to multiple
interacting proteins associated with the cell cycle, including cyclin
D3, retinoblastoma protein (pRb), and PCNA [68] [69] [70] [71]
[72] [73], although further investigations will be required in this
regard. Clearly, there are some specific cell-cycle alterations due to
manipulation of lamin A. The knockdown of A-type lamins by
MO1 resulted in an arrest of the cell cycle via both an S and M
phase block. On the other hand, induced cryptic splicing within
exon 11 by MO2 led to increased S phase entry/accumulation
without largely affecting M phase to any greater extent. Any
linkage of these cell-cycle regulatory mechanisms to apoptosis
versus senescence will need further extensive analyses. In this
regard, with the exception of p21WAF1/CIP1, no remarkable
differences in the mRNA levels of the cyclins and cdks were
observed in our current experiments. As a cyclin-dependent kinase
inhibitor, p21 binds and inactivates cyclin-cdk2 or cdk4 complexes
including cyclin D3/cdk4 which has been shown to be responsible
for the phosphorylation of pRb [74]. p21 also interacts with PCNA
and blocks its ability to activate S phase DNA replication and
DNA damage repair [74]. Presumably at the inner nuclear
membrane, lamin A orchestrates a functional network of the three
interacting proteins, cyclin D3, pRb and PCNA under the control
of p21 in cell cycle. In addition to the cell-cycle control, p21 can
play either anti- or pro-apoptotic roles in cells and also mediate
cellular senescence [74]. Hence, it is not entirely surprising that the
decrease-of-function of lamin A/C by MO1 and the gain-of-
function of zlamin A-D8 by MO2 could have such distinct effects
on cell cycle, apoptosis and senescence in zebrafish embryos. Since
further global gene expression changes as well as epigenetic
alterations would be anticipated upon the disruption of lamin A
functions [75] [76], the organization and modification of naive
chromatin might be worth consideration in future studies.
The phenocopies observed in several zebrafish tissues such as
muscle, adipose and skin with their short lifespan as found in
human progeria and laminopathies are extremely intriguing. As
for the LMNA function in our zebrafish progeria model, it should
be noted that the decrease-of-function of LMNA showed specific
developmental defects without any significant induction of SA-b-
gal i.e. embryonic senescence. By contrast, specific gain(s)-of-
function(s) of farnesylated forms of progerin and prelamin A could
play a crucial role(s) in the pathogenesis of the fish progeroid
(senescence) phenotype which was reduced by FTI at least in
zProgerin embryos. Therefore, the farnesylated progerin and an
excess of farnesylated prelamin A may essentially become
pathogenic and induce a progeroid phenotype in addition to
other laminopathy phenotypes. This would be consistent with the
recent observation that exclusive expression of farnesylatable
progerin elicited a relatively more severe progeroid phenotypes
than those of its non-farnesylated form in knock-in mice [37]. On
the other hand, exclusively expressed non-farnesylated prelamin A
still induced prominent cardiomyopathy but not progeria in
knock-in mice, whereas the survival of such mice which exclusively
produce farnesylatable prelamin A was very similar to that of wild-
type mice [38], which is quite possibly due to the lower amount of
farnesylated prelamin A. Embryonic senescence and further
unforeseen developmental abnormalities may also be occurring
in human (or mice) progeria given that severe neonatal lethality
has been reported [15] [77] [78].
The power of the zebrafish model lies in its ability to
accommodate genetic screens to identify responsible or modifier
genes and also facilitate compound screens to identify new
chemicals that influence developmental processes and signaling
pathways. In our current study, we used this tractable system to
analyze both embryonic and adult premature senescence, which
we modeled on severe pediatric progeroid disease in humans. By
generating the stable transgenic zebrafish lines that expresses
zProgerin as well as by transiently manipulating the LMNA-MOs
in early developmental stages of zebrafish embryos, premature
aging can now be assumed to be adequately modeled in this
system. The fairly late onset of progeria after germline transmis-
Figure 6. A lipodystrophic phenotype is caused by the
zebrafish lamin A/C knockdown. Lateral view of 5 dpf larvae
stained with Oil Red O. Strong staining can be observed around the
head, the otic vesicle, the jaw, the swim bladder and the heart, as well
as in the yolk of the Cont-MO-injected larvae. In contrast, in zLMNA-
MOs-injected embryos, obvious defects in lipid deposits can be
observed in all the tissues except the swim bladder. Duplicate samples
are shown for each MO-injected specimen.
doi:10.1371/journal.pone.0017688.g006
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Figure 7. FTI treatment of zprogerin/zlamin A-D37 transgenic zebrafish. (A) External features of zprogerin transgenic zebrafish (30 hpf)
without (Control, -FTI) or with FTI treatment (100 mM, +FTI). (B) Amelioration of nuclear morphology by FTI treatment (100 mM, +FTI) in comparison
with untreated (-FTI) zprogerin fish. Analysis of the misshapen nuclear morphology was also performed by using different concentrations of FTI in
zprogerin transgenic embryos at 30 hpf as shown in right graph. The number of cells with abnormally shaped nuclei were determined by
fluorescence microscopy (*P,0.05). (C) Amelioration of muscle phenotype (stained with the F59 antibody) at 24 hpf and reduction of SA-b-gal
activity at 3.5 dpf in zprogerin fish embryos by FTI treatment (100 mM, +FTI) in comparison with the untreated condition (-FTI). (D) Western blot
analysis of prelamin A accumulations in AB9 zebrafish fibroblasts following FTI treatment, and the quantitation of prelamin A amounts in right graph.
The quantifications of intrinsic prelamin A accumulations were shown are the averages from two-independent experiments.
doi:10.1371/journal.pone.0017688.g007
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Figure 8. Demographic analysis of the lifespan in zprogerin and zprelamin A transgenic zebrafish. A shorter lifespan in zprogerin and
zprelamin A transgenic zebrafish is demonstrated by Kaplan-Meier survival analysis. In zprogerin transgenic zebrafish (Progerin Tg), two independent
cohorts (Cohort 1 and 2) were analyzed and the survival curves show significant decreases in lifespan compared with the corresponding wild-type
siblings (Non-Tg siblings). zPrelamin A transgenic zebrafish (Prelamin Tg) also showed a relatively shorter lifespan than their siblings (Non-Tg siblings).
doi:10.1371/journal.pone.0017688.g008
Table 2. Summary of distinct zebrafish models for laminopathy in this study.
zLamin A-D37
(zProgerin) zLamin A-D8 zPrelamin A zLMNA-MO1
zLMNA-MO2
zLMNA-MO2.1
Approach Transgenic expression Transgenic
expression
Transgenic expression Transgenic expression Splice block of zLMNA in
Exon 11 (to generate zLamin
A-D8)
Nuclear Morphology Misshapen Misshapen Almost normal,
occasionally misshapen
N.A. N.A.
Gross Body Morphology Almost normal (in
embryos) Early body
curvature (in adults)
Almost normal
(in embryos)
Almost normal (in
embryos) Early body
curvature (in adults)
Almost normal
(in embryos)
Almost normal (in embryos)
Skin Phenotype Rough (in embryos) N.A. N.A. Rough (in embryos) Rough (in embryos)
Muscle Phenotype (F59)* Deficit in smooth
muscle (in embryos)
N.A. N.A. Deficit in smooth
muscle (in embryos)
Deficit in smooth muscle (in
embryos)
Craniofacial Phenotype
(Alcian blue)**
N.A. N.A. N.A. Deficit in cartilage
(in embryos)
Normal (in embryos)
Lipid (Oil red O)** N.A. N.A. N.A. Deficit: Decreased lipid;
Decreased PPARc (in
embryos)
Deficit: Decreased lipid;
Decreased PPARc (in
embryos)
Apoptosis (TUNEL)*** N.A. N.A. N.A. Induced (in embryos) Weakly induced (in
embryos)
Cell Cycle (BrdU, pH 3)* N.A. N.A. N.A. Deficit: Decreased S
phase; Decreased M
phase (in embryos)
Deficit: Increased S phase;
Decreased M phase (in
embryos)
Senescence (SA-b-gal)*** Induced (in embryos)
Weakly induced
(in adults)
N.A. Induced (in adults) Not detectable
(in embryos)
Induced (in embryos)
Lifespan Shortened N.A. Shortened N.A. N.A.
N.A.: not applied or analyzed in this study.
*Antibody-mediated detection.
**Dye-mediated detection.
***Phenotype-specific assay.
doi:10.1371/journal.pone.0017688.t002
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sion of the transgene made it easier to propagate this stable line.
Of note, however, later than fourth generations of transgenic lines
onwards showed a gradual decrease in the expression of GFP-
zProgerin and no longer maintained a steady-state expression of
the transgene further over the multiple generations. Technology to
render higher expressing transgenic progerin alleles via induction
would also be very valuable for in vivo use in the zebrafish, and we
are currently testing this approach for its capacity to generate large
numbers of different vector-based and promoter-driven transgenic
fish for subsequently stable genetic manipulations.
The utility of zebrafish to perform screens for small molecules
that perturb or restore normal development has been demonstrat-
ed [79] [80]. Our reverse-genetic progeroid zebrafish model may
also provide the opportunity to conduct large-scale screens for new
drugs for the prevention and treatment of normal aging and age-
associated diseases in addition to progeria and laminopathies.
Materials and Methods
Zebrafish maintenance and ethics
Zebrafish were maintained with a 14:10 h light/dark cycle and
fed living brine shrimp twice daily. Brine shrimp were given using
1 mL pipettes at an amount of about 0.75 mL brine shrimp per 20
fish. Flake food was also given every other day semiquantitatively
according to the number of fish in the tanks. A continuously
cycling Aquatic HabitatsTM system was used to maintain water
quality (Apopka, FL) which completely replaces the water in each
tank every 6–10 min. Each tank used was a baffle/tank system
that eggs water in a circular motion to ensure flushing and water
turnover. Ultraviolet (UV) sterilizers (110,000 mW-s cm22) were
employed to disinfect the water and prevent the spread of disease
in the recirculating system. The water temperature was main-
tained at 2860.5uC. The system continuously circulated water
from the tanks through SiporaxTM strainers, through a fiber
mechanical filtration system (three different pore-sized filters; one
pre-pad filter of 120 mm, two bag filters of 100 and 50 mm,
respectively), and finally into a chamber containing foam filters
and activated carbon inserts. Water quality was tested daily for
chlorine, ammonia, pH, nitrate and conductivity, and also was
under real-time computer monitoring with alarms to signal
potential fluctuations. The general health of each fish was also
observed on a daily basis, and abnormal looking or acting fish
were quarantined into isolated tanks that were not connected to
the general circulation. The water in these quarantined tanks was
treated with methylene blue. If and when fish recovered, they were
returned to their original tanks on the general circulation system.
The zebrafish embryos were staged by hours post fertilization (hpf)
at 28.5uC and also by morphological criteria for experiments [81].
All animal experiments were approved by and conducted in
accordance with the guidelines established by the Institutional
Animal Care and Use Committee (IACUC) at The Scripps
Research Institute, IACUC approval number 09-0009 and The
Schepens Eye Research Institute, IACUC approval number S-
150-0909 and S-186-1210.
Molecular cloning of zebrafish lamin A/C
To isolate the full length zebrafish lamin A/C cDNA, the
zebrafish lamin A mRNA sequence deposited in GenBank was
used (accession number AF397016) [82]. mRNA was isolated from
zebrafish embryos at 24 hpf using QuickPrep mRNA purification
Kit (Amersham Biosciences, Uppsala, Sweden). Poly(A) RNA was
then purified with oligo(dT)-resin. Double-stranded cDNA was
synthesized using M-MLV reverse transcriptase (Promega, Madi-
son, WI), followed by PCR by ExTaq (Takara Mirus Bio, Madison,
WI). The primers used were as follows: forward (F): 59-
ATGGAGACTCCAGGTCAGAAAC-39, reverse (R): 59-AAG-
CACAGATGGTCAGGGTTTG-39. The PCR program entailed
a 30-cycle amplification for 30 sec at 94uC, 30 sec at 60uC, and
4 min at 72uC. The amplified DNA fragments were purified by
excision from an agarose gel, and cloned into the pCRII-TOPO
cloning vector (Invitrogen, Carlsbad, CA). Nucleotide sequences
were determined with an automated sequencer (ABI 3700, AME
Bioscience, Norway) using the ABI BigDye V3.1 cycle sequencing
system.
To analyze the full-length sequence of the zebrafish lamin C
gene, 39- rapid amplification of cDNA ends (39-RACE) was
performed with a Generacer kit (Invitrogen). A forward primer
(59-CAGAACTCATGGGGCAGCGGTGATTTGT-39; residues
535-544 of zebrafish lamin A) and a forward nested primer (59-
GCGGTGATTTGTTCCAGACCACCCTCAT-39; residues
540–549 of zebrafish lamin A) were used to amplify the 39-end
portion of the zebrafish cDNA by PCR in conjunction with the
adapter primer supplied with the kit (Invitrogen). PCR was
performed according to the manufacturer’s instructions using
10 ng of cDNA template and 1 ng of each primer in a total volume
of 50 ml per sample. The samples were subjected to touchdown
PCR (2 min at 94uC, 5 cycles of 30 sec at 94uC and 2 min at 72uC,
5 cycles of 30 sec at 94uC and 2 min at 70uC, and 25 cycles of
30 sec at 94uC, 30 sec at 65uC, and 120 sec at 72uC). The amplified
DNA fragments were then subcloned into the pCRII-TOPO
cloning vector and sequenced. Multiple sequence alignments were
carried out using Megalign software (DNAstar, Madison, WI). All
parameters were set at default. A full-length zebrafish lamin A
cDNA fragment was subcloned into the KpnI and BamHI sites of the
pEGFP-C1 Vector (Clontech, Mountain View, CA).
Whole mount mRNA in situ hybridization of embryos
For in situ hybridization, digoxigenin-labeled antisense RNA
probes were synthesized from the 2.0 kb zebrafish lamin A/C
insert which had been directionally subcloned into the pCRII-
TOPO vector (Invitrogen) using an in vitro transcription kit (Roche
Applied Science, Indianapolis, IN). Antisense mRNA was
transcribed from the XbaI-linearized plasmid using SP6 polymer-
ase, and sense mRNA from the KpnI-linearized plasmid using T7
polymerase as a control. In situ hybridization analyses and
development of whole-mount zebrafish embryos were performed
as previously described [83] [84].
RNA isolation and RT-PCR analysis for zebrafish lamin A/C
Total RNA was extracted from 24 hpf embryos using TRIzol
reagent according to the manufacturer’s protocol (Invitrogen).
Double-stranded cDNA was synthesized using M-MLV reverse
transcriptase (Promega), followed by PCR with ExTaq (Takara). For
RT-PCR analysis of zlamin A/C, the forward and reverse primers
used were 59- TCAGCAAAGTGCGTGAGGACTACA-39 and 59-
GCGAAGCTGCTCTTCATGTTGGTT-39. Specifically for zla-
min A, the forward and reverse primers used were 59-TTTG-
TTCCAGACCACCCTCATC-39 and 59-AAGCACAGATGGT-
CAGGGTTTG-39: and for zlamin C, 59-TGGCAGGTGAA-
GAGGCAGATTG-39 and 59-GACCCGCAACATAAAGGCTA
-39. For the detection of the cryptic splicing region in lamin A exon
11 caused by MO (zLMNA-MO2 and zLMNA-MO2.1) injections,
the primers used were as follows: forward, 59-TTTGTTCCAGAC-
CACCCTCATC-39 and reverse, 59-AAGCACAGATGGT-
CAGGGTTTG-39 (as described above). As for the control primers,
the forward and reverse primers used to amplify EF1a were 59-
ACCACCGGCCATCTGATCTACAAA-39 and 59-ACGGATG-
TCCTT GACAGACACGTT -39, respectively. The forward and
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reverse primers used to amplify b-actin were 59-CCCAGACAT-
CAGGGAGTGAT-39 and 59-CACCGATCCAGACGGAGTAT-
39, respectively [85]. For amplification by PCR, the initial
denaturing step at 94uC for 5 min was followed by 25 amplification
cycles of 30 sec at 94uC; 30 sec at 60uC; 60 sec at 72uC, and a final
extension period of 10 min at 72uC. Each amplification reaction
was separated on a 1.5% agarose gel stained with ethidium
bromide-stain and the bands were visualized and recorded using a
Multi Image Light Cabinet (Cell Bioscience, Santa Clara, CA).
Morpholino oligonucleotides
Morpholino oligonucleotides (MOs) were designed and synthe-
sized by Gene Tools, LLC (Philomath, OR), to target the 59-
translation start site (zLMNA-MO1) and the eleventh exon-intron
junction (zLMNA-MO2 and zLMNA-MO2.1) of the zebrafish LMNA
gene. The MO sequences were as follows: zLMNA-MO1, 59-
CATGGTTGTCTGGAACTACTGATA-39; zLMNA-MO2, 59-
ACATACAGTACACACCTGTCTGGGT-39; zLMNA-MO2.1;
59-ACACATACAGTACACACCTGTCTGG-39; 5-base mismatch
control for zLMNA-MO1 (MO1-5-mis), 59-CATGcTTcTgTG-
cAACTACTcATA-39 (mispairing bases are indicated in lowercase);
5-base mismatch control for zLMNA-MO2 (MO2-5-mis), 59-
ACATAgAcTACAgACCTcTCTcGGT-39. MOs were re-suspend-
ed in sterile water at a concentration of 1 mM as stock solutions. For
microinjection into embryos, the stock solutions (1 mM) were diluted
to 125, 250, and 500 mM. A 10 nl volume of each MO solution was
injected into the yolk during the one-cell stage. For transfection into
cultured cells, the stock solution was diluted to 30 mM as a final
concentration. Zebrafish AB9 fibroblast cells were cultured in
DMEM supplemented with 15% heat-inactivated feral bovine serum
(FBS) and grown in a humidified 5% CO2-containing incubator at
28.5uC. Endo-Portor (Gene Tools) was used to help cells incorporate
zLMNA MOs.
Western blot analysis
The zebrafish cells, embryos, and the tissues of adults were
homogenized in RIPA buffer supplemented with one tablet of
protease inhibitor cocktail (Roche Applied Science)/10 ml on ice.
The protein extracts were then fractionated on 10% SDS-
polyacrylamide gels and transferred to PVDF membranes (Bio-
Rad, Hercules, CA). The blot was incubated with the primary
antibody diluted in TBST (1:2000 dilution anti-lamin A antibody,
ab14309; Abcam, Cambridge, MA) overnight at 4uC. After
washing, the blot was then incubated with the secondary anti-IgY
antibody (1:2000 dilution, ab6753; Abcam) at room temperature
for 1 h and visualized using an ECL kit (Perkin Elmer, Waltham,
MA) in accordance with the manufacturer’s instructions. In
addition, reactivity with an actin antibody (AC-40; Sigma-Aldrich,
St. Louis, MO) at a dilution of 1:1000 was used to normalize the
loading per lane.
Antibody staining for muscle and Alcian blue staining for
cartilage
Antibody staining for muscle of zebrafish embryo was
performed as previously described [86]. The following primary
antibodies were used for immunostaining: 24 hpf embryos for F59
(1:100) and 48 hpf embryos for F310 (1:100) (DSHB, Iowa City,
IW). Immunoreactivity was detected using a rhodamine (TRITC)-
conjugated anti-mouse secondary antibody (Southern Biotechnol-
ogy Associates, Birmingham, AL) diluted in blocking solution (PBS
containing 1% BSA, 2% Normal goat serum, 0.1% Tween-20, 1%
DMSO) (1:250). Fish larvae at 6 dpf were stained with Alcian blue
to visualize cartilage as previously described [87].
Senescence-associated b-gal activity (SA-b-gal) assay of
zebrafish embryos
Zebrafish larvae at 3.5–6 dpf were washed in phosphate buffer
saline (PBS) three times and fixed overnight in 4% paraformal-
dehyde (PFA) with PBS at 4uC. Adult zebrafish were also washed
in PBS 3 times and fixed for 3 days in 4% PFA in PBS. After
fixation, samples were washed 3 times in PBS, pH 7.5, twice again
in PBS, pH 6.0 at 4uC, and then incubated at 37uC (in the absence
of CO2) for 12–16 h with SA-b-gal staining solution (5 mM
potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM
MgCl2 in PBS at pH 6.0). Staining intensity was quantified by
pixel analysis using with Adobe Photoshop CS software as
described previously [42].
Apoptosis detection and Immunohistochemistry
Embryos at 24–48 hpf, were fixed overnight in 4% PFAwith PBS
at 4uC and stored in 100% methanol at 220uC until samples were
used. Samples were then incubated in 100% acetone at 220uC for
20 min. Following fixation, the embryos were rinsed three times
with PBS containing 0.1% Tween-20 (PBST; 5 min each). Samples
were then permeabilized by treatment with 0.5% Triton X-100 and
0.1% sodium citrate in PBS for 15 min, then with 5 to 50 mg/ml
proteinase K (Invitrogen) for 5 to 25 min depending on embryo
stages. Embryos were subjected to TUNEL assay by using the
ApopTag Red in situ Apoptosis Detection Kit (Chemicon,
Temecula, CA) according to the manufacture’s instruction.
For whole-mount pH 3 antibody staining, embryos at 24 hpf
were fixed overnight in 4% PFA with PBS at 4uC, incubated in
100% methanol at220uC, and then treated with 100% acetone at
220uC for 7 min. After fixation, embryos were rinsed in 50%
PBS/50% methanol at 220uC for 1 h, rinsed once in water and
then twice in PBST (5 min each). Embryos were blocked for 1 h in
blocking solution (PBS containing 1% BSA, 2% Normal goat
serum, 0.1% Tween-20, 1% DMSO) and then incubated
overnight at 4uC with a polyclonal anti-pH 3 (Ser10) antibody
(Upstate-Millipore, Billerica, MA) (1:200). Finally, the embryos
were washed 4 times in PBS-DT (PBS including, 0.1% Tween-20
and 1% DMSO) for 15 min, and incubated in TRITC-conjugated
anti-rabbit secondary antibody (Southern Biotechnology) (1:300)
in blocking solution for 4 h at room temperature.
BrdU (Sigma) with a final concentration of 10 mM was dissolved
in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2,
0.33 mM MgSO4) containing 15% dimethyl sulfoxide (DMSO).
Embryos at 24 hpf were soaked in the BrdU solution for 20 min at
6uC, then incubated for 5–10 min at 28.5uC. Samples were fixed for
2 h in 4% PFA with PBS at room temperature, rinsed twice in PBS,
incubated in 2 N HCl for 30 min at room temperature, and
transferred in 0.1 M Tris-HCl (pH 7.5) for 5 min, blocked in FCS-
PBST (10% fetal calf serum, 1% DMSO, in PBST) solution for
30 min, and incubated with anti-BrdU Cy3-labeled antibody (BD-
Biosciences-Pharmingen, San Jose, CA) (1:100).
Anti-PCNA FITC-labeled antibody (BD-Biosciences-Pharmin-
gen,) (1:100) staining was performed by the same procedure done
in pH3 antibody staining as described above, except the secondary
antibody.
Detection and quantitation of visible and fluorescent
images
All animals were photographed under the same conditions using
reflected light (for SA-b-gal) or fluorescence (for BrdU and pH 3)
under a macro microscope, AZ100 (Nikon). SA-b-gal activity in
each animal was quantitated using a selection tool in Adobe
Photoshop for a color range that was chosen by 25 additive blue
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color selections of regions that showed visually positive SA-b-gal
staining. For analyses of embryos, these regions were selected in
each embryo proper only and not in the yolk. This was to
eliminate variability due to differences in initial yolk volume and
yolk consumption over time. Since the yolk stains much more
intensely blue for SA-b-gal at all stages of development than any
other embryonic tissues, it was desirable to exclude this as a source
of variability. Following pixel selection, a fuzziness setting of 14
was used, and the chosen pixel number was calculated using the
image histogram calculation. Incorporated BrdU and pH 3
positive cells in each animal were quantitated in the same way
except that a fuzziness setting of 64 was used.
Oil red O staining
Zebrafish larvae at 5 dpf were PBS three times and fixed
overnight in 4% PFA with PBS at 4uC. After fixation, samples
were washed twice in PBS, followed by oil red O staining in freshly
filtered 0.3% oil red O in 60% 2-propanol for 30 min to 2 h [54].
Samples were quickly washed in 60% 2-propanol for a few times,
and then finally washed once in PBS.
Semi-quantitative RT-PCR
First strand cDNA was generated using total RNA that had
been isolated from LMNA MO- and 5-base mismatch control (5-
mis) MO-injected 24 hpf embryos with Trizol (Invitrogen). The
linear amplification ranges were then determined for each of the
primer sets as described previously [85]. Primers used to amplify
the zebrafish cdk2 and PPARc genes were designed using Genetyx
mac software (cdk2, forward primer: 59-AGTTACAGGA-
GAAACTGTCGCGCT-39, reverse primer: 59-AGCGTTCT-
TTGCCGAGATCCTCTT-39; PPARc, forward primer: 59-
AAGAGCCGCAACAAGTGCCAATAC-39; reverse primer: 59-
AGAACTCGAACTTGGGCTCCATCA-39). All other primer
sequences had been reported previously by Liu et al. [85]. PCR
conditions were as follows: an initial denaturing step at 94uC for
5 min was followed by 25 amplification cycles of 30 sec at 94uC;
30 sec at 60uC; 60 sec at 72uC, and a final extension period of
10 min at 72uC.
Generating transgenic zebrafish
To generate transgenic zebrafish expressing EGFP-tagged
zProgerin/zlamin A-D37, the corresponding expression construct
was generated using the QuikChange Site-Directed Mutagenesis
Kit (Stratagene, La Jolla, CA) in accordance with the manufac-
turer’s instructions. This vector was then injected into one-cell
stage embryos with meganuclease I-SceI [88] [89]. Germline
transgenic founders (F0) were identified by screening F1 embryos
via PCR. Four founder transgenic fish carrying the EGFP-
zProgerin DNA construct were thus identified. F1 embryos of these
transgenic founders were then allowed to grow to maturity. Adult
transgenic fish of the F1 generation were screened individually by
PCR using DNA extracted from their caudal fins. For genotyping,
EGFP-specific primers (EGFP-sense: 59-TCTTCTTCAAGGAC-
GACGGCAACT-39 and EGFP-antisense: 59-TGTGGCGGA-
TCTTGAAGTTCACCT-39) and control PCR primers (Wnt5a-
sense: 59-CAGTTCTCACGTCTGCTACTTGCA-39 and Wnt5a-
antisense: 59-ACTTCCGGCGTGTTGGAGATTTC-39) were
mixed and 1 mM of each was used in a PCR reaction with a final
volume of 25 ml.
Drug treatments
The farnesyltransferase inhibitor FTI L-744832 (Biomol,
Plymouth Meeting, PA) was resuspended in DMSO (50 mM).
For FTI treatment, cells were cultured to 70% confluence, and
treated with 5, 10, and 20 mM of the inhibitor in cell culture
medium for 72 h until harvesting. Embryo FTI treatments (20, 40,
and 100 mM) were performed from 5 through 30 hpf in E3
medium with 1% DMSO at 28.5uC.
Quantitative analysis and statistics
Data processing and statistical analyses were performed using
Statistical Package for the Social Sciences (SPSS) version 14.0.
This software was used to generate each of the scatter plots, tables
and graphs shown in the text and perform statistical tests where
appropriate. Additional statistical analyses were performed using a
custom MATLAB script to analyze survival estimates by the
method of Kaplan and Meier, and to compare of survival between
mutant fish and their wild type controls using the log rank test
[90].
Supporting Information
Figure S1 The sequence and genetic organization of
zebrafish lamin A/C is conserved with human lamin A/
C. The zebrafish lamin A/C gene (zlamin A/C) comprises 12
exons, encoding two globular domains and a rod domain; zlamin
C is encoded by exons 1 to 9.
(TIF)
Figure S2 Expression of zebrafish lamin A/C in adult
fish. Immunofluorescence microscopy of 1-year old adult
zebrafish fin cells in situ. The immunostaining reveals that
zebrafish lamin A/C is localized to the nuclear envelope.
(TIF)
Figure S3 Expression of zebrafish lamin A/C during
early development. (A) RT-PCR analysis of zlamin A/C,
zlamin A and zlamin C during early development. (B) Expression
patterns of zlamin A/C during early development (0.75 to 72 hpf)
(a–e, g, i, k, and n are lateral views; f, h, j, m, and p are dorsal
views; l, and o are ventral views. pf: pectoral fin; op: opercle).
(TIF)
Figure S4 Schematic representation of the nucleotide
sequences targeted by zLMNA-MO2 and zLMNA-MO2.1.
The nucleotide sequences of exon 10 (Ex. 10), intron between
Ex.10 and exon 11 (Ex. 11), Ex. 11, and intron between Ex.11 and
exon 12 (Ex. 12) are shown with the annealing portions of zLMNA-
MO2 (MO2) and zLMNA-MO2.1 (MO2.1).
(TIF)
Figure S5 MO-injected embryos stained with anti-
PCNA. Lateral views of MO-injected embryos at 24 hpf stained
with the PCNA antibody.
(TIF)
Figure S6 PPARc mRNA expression in lamin A/C
morphants. The expression of zebrafish PPARc in the
morphants was semi-quantitatively analyzed by single-embryo
RT-PCR at 72 hpf. Two independent samples (lanes 1 and 2) for
MO1 (both 5-mis and MO) and MO2 (both 5-mis and MO) were
loaded in the lanes (upper picture panels). In quantitation (lower
graph panel), the expression levels of PPARc mRNA were
significantly decreased in zLMNA-MO-injected (MO) embryos in
comparison with the controls (5-mis) (P,0.01 for 5-mis versus MO
in MO1 and MO2).
(TIF)
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